Currently, early screening for LC mainly relies on abdominal ultrasonography and serum alpha-fetoprotein (AFP) testing, which have relatively limited sensitivity, especially in patients without cirrhosis [7]. This evidence concerns the gene AFP and laryngotracheoesophageal cleft.